Happy Friday!
After a challenging 2020, OMERS Private Equity returned to growth mode this year, working a post-covid deal pipeline “as full as it ever has been,” global head Michael Graham told Buyouts’ Kirk Falconer.
Investing to date this year, totaling C$1.6 billion ($1.3 billion), represents “slightly above average” activity for OMERS, Graham said. The “velocity of deals,” however, amounts to “one of our biggest years yet.”
Going after those assets it believes it has “the right to own”, one of three new platforms in the first half of the year included Gastro Health, a Miami-based gastroenterology physician practice management company acquired from Audax Private Equity at a TEV of roughly $950 million, I wrote.
That’s it for me! Have a great weekend, and as always, write to me at [email protected] with any tips, comments or just to say hello.
Read the full wire commentary on PE Hub...